UBS’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.86M Buy
199,447
+123,939
+164% +$3.78M ﹤0.01% 1878
2014
Q2
$2.15M Buy
75,508
+417
+0.6% +$11.6K ﹤0.01% 2795
2014
Q1
$2.15M Buy
75,091
+62,717
+507% +$1.63M ﹤0.01% 2714
2013
Q4
$328K Buy
12,374
+7,761
+168% +$216K ﹤0.01% 4763
2013
Q3
$127K Buy
4,613
+364
+9% +$9.34K ﹤0.01% 5740
2013
Q2
$97K Buy
+4,249
New +$96K ﹤0.01% 5944

Other funds holding EHC

UBS's EHC Position: Q3 2014 in Review

UBS increased its Encompass Health (EHC) stake by 164% in Q3 2014, buying an estimated $3.78M and bringing the position to 199,447 shares worth $5.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

UBS first reported a position in EHC in Q2 2013 and has held it in 6 quarters since. 222 funds tracked by Wall St. Rank hold EHC as of Q3 2014.

  • UBS held 199,447 shares of Encompass Health worth $5.86M as of Q3 2014.
  • UBS bought 123,939 Encompass Health shares in Q3 2014, an estimated $3.78M.
  • Encompass Health made up ﹤0.01% of UBS's portfolio in Q3 2014, its #1878 holding.
  • UBS first reported a position in Encompass Health in Q2 2013 and has held it in 6 quarters since.
  • 222 funds tracked by Wall St. Rank held Encompass Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.